logo
logo
Sign in
kriti singh 2021-03-26
img

The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period.The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R spending & healthcare expenditure.

Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.

However, quality concerns over antibodies are the major challenge in this market.To know about the assumptions considered for the study, Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=255585571The kits segment accounted for the highest growth rate in the Immunofluorescence assay market, by product, during the forecast periodThe Immunofluorescence assay market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories.

The kits segment accounted for the highest growth rate in the Immunofluorescence assay market in 2020.

The demand for complete solutions from a single provider, like closed-system reagents with calibrated measurements of the required quantity of reagents and controls, among CROs, academic institutes, and research institutes is growing, contributing to this segment's high growth rate.Indirect immunofluorescence segment accounted for the highest CAGRBased on type, the immunofluorescence assays market is segmented into indirect immunofluorescence and direct immunofluorescence.

The major factors driving the growth of this segment are its advantages such as sensitivity, flexibility, better amplification of the signal, and lower cost over direct immunofluorescence.Cancer accounted for the largest share of the immunofluorescence assay market in 2020Based on disease, the immunofluorescence assays market is segmented into cancer, infectious diseases, autoimmune diseases, cardiovascular diseases, and other diseases.

collect
0
kriti singh 2021-04-22
img

The study involved four major activities in estimating the current size of the immunofluorescence assay market.

Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571Major Market Growth Drivers: The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R spending & healthcare expenditure.

Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.

However, quality concerns over antibodies are the major challenge in this market.Revenue Growth Analysis: [203 Pages Report] The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period.

collect
0
kriti singh 2021-07-05
img

The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R spending & healthcare expenditure.

Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.

However, quality concerns over antibodies are the major challenge in this market.The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571Reagents accounted for the larger share of the share of global immunofluorescence assays market in 2020By product, the immunofluorescence assays market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories.

The reagents segment accounted for for the largest share of global immunofluorescence assays market.

This can be attributed to the wide use of reagents in assay techniques and the need for repeat purchases.To know about the assumptions considered for the study, Request for Sample ReportPharmaceutical & biotechnology companies accounted for the largest share of the immunofluorescence assay market in 2020Based on end user, the immunofluorescence assays market is segmented intopharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostics centers, and contract research organizations.

The pharmaceutical & biotechnology companies accounted for the largest share of the global immunofluorescence assays market.

collect
0
Ritika Tyagi 2021-06-09
img

COVID-19 has disrupted healthcare services in most countries worldwide; the worst affected are the US, Russia, Spain, Italy, the UK, India, Germany, and Iran.Immunofluorescence assays are used extensively for the detection of viral antigens, including COVID-19.

As a result, the pandemic has increased the demand for immunofluorescence assay products across the globe.

These are fast and simple methods that allow researchers to visualize the effects and dynamics of viral infections.

In the current global scenario, such methods represent a crucial tool in preventing and treating these pathogens.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R spending & healthcare expenditure.

Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.

However, quality concerns over antibodies are the major challenge in this market.The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period.Reagents accounted for the larger share of the share of global immunofluorescence assays market in 2020 By product, the immunofluorescence assays market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories.

collect
0
kriti singh 2021-08-06
img

The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R spending & healthcare expenditure.

Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.

However, quality concerns over antibodies are the major challenge in this market.The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571Reagents accounted for the larger share of the share of global immunofluorescence assays market in 2020By product, the immunofluorescence assays market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories.

The reagents segment accounted for for the largest share of global immunofluorescence assays market.

This can be attributed to the wide use of reagents in assay techniques and the need for repeat purchases.To know about the assumptions considered for the study, Request for Sample ReportPharmaceutical & biotechnology companies accounted for the largest share of the immunofluorescence assay market in 2020Based on end user, the immunofluorescence assays market is segmented intopharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostics centers, and contract research organizations.

The pharmaceutical & biotechnology companies accounted for the largest share of the global immunofluorescence assays market.

collect
0
kriti singh 2021-03-26
img

The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period.The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R spending & healthcare expenditure.

Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.

However, quality concerns over antibodies are the major challenge in this market.To know about the assumptions considered for the study, Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=255585571The kits segment accounted for the highest growth rate in the Immunofluorescence assay market, by product, during the forecast periodThe Immunofluorescence assay market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories.

The kits segment accounted for the highest growth rate in the Immunofluorescence assay market in 2020.

The demand for complete solutions from a single provider, like closed-system reagents with calibrated measurements of the required quantity of reagents and controls, among CROs, academic institutes, and research institutes is growing, contributing to this segment's high growth rate.Indirect immunofluorescence segment accounted for the highest CAGRBased on type, the immunofluorescence assays market is segmented into indirect immunofluorescence and direct immunofluorescence.

The major factors driving the growth of this segment are its advantages such as sensitivity, flexibility, better amplification of the signal, and lower cost over direct immunofluorescence.Cancer accounted for the largest share of the immunofluorescence assay market in 2020Based on disease, the immunofluorescence assays market is segmented into cancer, infectious diseases, autoimmune diseases, cardiovascular diseases, and other diseases.

kriti singh 2021-07-05
img

The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R spending & healthcare expenditure.

Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.

However, quality concerns over antibodies are the major challenge in this market.The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571Reagents accounted for the larger share of the share of global immunofluorescence assays market in 2020By product, the immunofluorescence assays market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories.

The reagents segment accounted for for the largest share of global immunofluorescence assays market.

This can be attributed to the wide use of reagents in assay techniques and the need for repeat purchases.To know about the assumptions considered for the study, Request for Sample ReportPharmaceutical & biotechnology companies accounted for the largest share of the immunofluorescence assay market in 2020Based on end user, the immunofluorescence assays market is segmented intopharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostics centers, and contract research organizations.

The pharmaceutical & biotechnology companies accounted for the largest share of the global immunofluorescence assays market.

kriti singh 2021-08-06
img

The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R spending & healthcare expenditure.

Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.

However, quality concerns over antibodies are the major challenge in this market.The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571Reagents accounted for the larger share of the share of global immunofluorescence assays market in 2020By product, the immunofluorescence assays market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories.

The reagents segment accounted for for the largest share of global immunofluorescence assays market.

This can be attributed to the wide use of reagents in assay techniques and the need for repeat purchases.To know about the assumptions considered for the study, Request for Sample ReportPharmaceutical & biotechnology companies accounted for the largest share of the immunofluorescence assay market in 2020Based on end user, the immunofluorescence assays market is segmented intopharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostics centers, and contract research organizations.

The pharmaceutical & biotechnology companies accounted for the largest share of the global immunofluorescence assays market.

kriti singh 2021-04-22
img

The study involved four major activities in estimating the current size of the immunofluorescence assay market.

Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571Major Market Growth Drivers: The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R spending & healthcare expenditure.

Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.

However, quality concerns over antibodies are the major challenge in this market.Revenue Growth Analysis: [203 Pages Report] The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period.

Ritika Tyagi 2021-06-09
img

COVID-19 has disrupted healthcare services in most countries worldwide; the worst affected are the US, Russia, Spain, Italy, the UK, India, Germany, and Iran.Immunofluorescence assays are used extensively for the detection of viral antigens, including COVID-19.

As a result, the pandemic has increased the demand for immunofluorescence assay products across the globe.

These are fast and simple methods that allow researchers to visualize the effects and dynamics of viral infections.

In the current global scenario, such methods represent a crucial tool in preventing and treating these pathogens.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R spending & healthcare expenditure.

Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.

However, quality concerns over antibodies are the major challenge in this market.The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period.Reagents accounted for the larger share of the share of global immunofluorescence assays market in 2020 By product, the immunofluorescence assays market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories.